Literature DB >> 19297604

Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent.

Pieter W Uys1, Robin Warren, Paul D van Helden, Megan Murray, Thomas C Victor.   

Abstract

The long-term persistence of Mycobacterium tuberculosis in communities with high tuberculosis prevalence is a serious problem aggravated by the presence of drug-resistant tuberculosis strains. Drug resistance in an individual patient is often discovered only after a long delay, particularly if the diagnosis is based on current culture-based drug sensitivity testing methods. During such delays, the patient may transmit tuberculosis to his or her contacts. Rapid diagnosis of drug resistance would be expected to reduce this transmission and hence to decrease the prevalence of drug-resistant strains. To investigate this quantitatively, a mathematical model was constructed, assuming a homogeneous population structure typical of communities in South Africa where tuberculosis incidence is high. Computer simulations performed with this model showed that current control strategies will not halt the spread of multidrug-resistant tuberculosis in such communities. The simulations showed that the rapid diagnosis of drug resistance can be expected to reduce the incidence of drug-resistant cases provided the additional measure of screening within the community is implemented.

Entities:  

Mesh:

Year:  2009        PMID: 19297604      PMCID: PMC2681859          DOI: 10.1128/JCM.02289-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

Review 1.  Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century.

Authors:  L B Heifets; G A Cangelosi
Journal:  Int J Tuberc Lung Dis       Date:  1999-07       Impact factor: 2.373

2.  Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.

Authors:  Thomas C Victor; Petra E W de Haas; Annemarie M Jordaan; Gian D van der Spuy; Madalene Richardson; D van Soolingen; Paul D van Helden; Robin Warren
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  The use of a geographical information system (GIS) to evaluate the distribution of tuberculosis in a high-incidence community.

Authors:  N Beyers; R P Gie; H L Zietsman; M Kunneke; J Hauman; M Tatley; P R Donald
Journal:  S Afr Med J       Date:  1996-01

4.  Transmission of multidrug-resistant strains of Mycobacterium tuberculosis in a high incidence community.

Authors:  T C Victor; R Warren; N Beyers; P D van Helden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

5.  The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection.

Authors:  E Vynnycky; P E Fine
Journal:  Epidemiol Infect       Date:  1997-10       Impact factor: 2.451

6.  Directly observed therapy for tuberculosis given twice weekly in the workplace in urban South Africa.

Authors:  S Bechan; C Connolly; G M Short; E Standing; D Wilkinson
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

7.  Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients.

Authors:  A van Rie; R M Warren; N Beyers; R P Gie; C N Classen; M Richardson; S L Sampson; T C Victor; P D van Helden
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

8.  Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

Authors:  M A Behr; S A Warren; H Salamon; P C Hopewell; A Ponce de Leon; C L Daley; P M Small
Journal:  Lancet       Date:  1999-02-06       Impact factor: 79.321

9.  Transmission of tuberculosis in a high incidence urban community in South Africa.

Authors:  Suzanne Verver; Robin M Warren; Zahn Munch; Emilia Vynnycky; Paul D van Helden; Madalene Richardson; Gian D van der Spuy; Donald A Enarson; Martien W Borgdorff; Marcel A Behr; Nulda Beyers
Journal:  Int J Epidemiol       Date:  2004-04       Impact factor: 7.196

Review 10.  To control and beyond: moving towards eliminating the global tuberculosis threat.

Authors:  Timothy F Brewer; S Jody Heymann
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

View more
  16 in total

1.  Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.

Authors:  N Bablishvili; N Tukvadze; E Shashkina; B Mathema; N R Gandhi; H M Blumberg; R R Kempker
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.

Authors:  Ben J Marais; Charmaine K Mlambo; Nalin Rastogi; Thierry Zozio; Adriano G Duse; Thomas C Victor; Else Marais; Robin M Warren
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

Review 3.  Diagnostic point-of-care tests in resource-limited settings.

Authors:  Paul K Drain; Emily P Hyle; Farzad Noubary; Kenneth A Freedberg; Douglas Wilson; William R Bishai; William Rodriguez; Ingrid V Bassett
Journal:  Lancet Infect Dis       Date:  2013-12-10       Impact factor: 25.071

Review 4.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

5.  Naked eye detection of the Mycobacterium tuberculosis complex by recombinase polymerase amplification-SYBR green I assays.

Authors:  Nuntita Singpanomchai; Yukihiro Akeda; Kazunori Tomono; Aki Tamaru; Pitak Santanirand; Panan Ratthawongjirakul
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

Review 6.  Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries.

Authors:  Angelika Niemz; David S Boyle
Journal:  Expert Rev Mol Diagn       Date:  2012-09       Impact factor: 5.225

7.  Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis.

Authors:  David W Dowdy; Sanjay Basu; Jason R Andrews
Journal:  Am J Respir Crit Care Med       Date:  2012-12-21       Impact factor: 21.405

8.  The potential impact of new diagnostic tests on tuberculosis epidemics.

Authors:  Christopher Dye
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

9.  Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment.

Authors:  Timothy F Brewer; Howard W Choi; Carlos Seas; Fiorella Krapp; Carlos Zamudio; Lena Shah; Antonio Ciampi; S Jody Heymann; Eduardo Gotuzzo
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

Review 10.  Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.

Authors:  Alice Zwerling; Richard G White; Anna Vassall; Ted Cohen; David W Dowdy; Rein M G J Houben
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.